Semi-Annual Consolidated Statement Of Cash Flows

Japan Tissue Engineering Co., Ltd. - Filing #7332511

Concept As at
2024-03-31
2023-04-01 to
2024-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
As at
2022-03-31
Semi-annual consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
147,009,000 JPY
-725,477,000 JPY
Depreciation
134,048,000 JPY
131,453,000 JPY
Interest and dividend income
-782,000 JPY
-1,145,000 JPY
Increase (decrease) in provision for bonuses
34,439,000 JPY
684,000 JPY
Decrease (increase) in trade receivables
-32,428,000 JPY
-79,735,000 JPY
Decrease (increase) in inventories
9,056,000 JPY
-50,336,000 JPY
Increase (decrease) in trade payables
-52,333,000 JPY
18,829,000 JPY
Other, net
12,114,000 JPY
89,684,000 JPY
Subtotal
277,219,000 JPY
-620,292,000 JPY
Interest and dividends received
689,000 JPY
1,145,000 JPY
Income taxes paid
-3,770,000 JPY
-3,453,000 JPY
Net cash provided by (used in) operating activities
274,138,000 JPY
-622,600,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-195,909,000 JPY
-149,063,000 JPY
Other, net
180,000 JPY
651,000 JPY
Net cash provided by (used in) investing activities
-242,230,000 JPY
1,124,654,000 JPY
Cash flows from financing activities
Purchase of treasury shares
0 JPY
JPY
Net cash provided by (used in) financing activities
-134,000 JPY
-803,000 JPY
Net increase (decrease) in cash and cash equivalents
31,773,000 JPY
501,250,000 JPY
Cash and cash equivalents
2,066,344,000 JPY
2,034,570,000 JPY
1,533,319,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.